Venous thromboembolism (VTE), consisting of deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third most common cause of cardiovascular mortality worldwide after myocardial infarction and stroke. Despite continuous progress in anticoagulation, a specific preventive strategy against VTE that goes beyond anticoagulation is still lacking. In recent years, it has been shown that arterial and venous thromboembolism share more common risk factors than previously thought, including dyslipidemia and inflammatory processes.
Autoren
- Tanja Schliebe
Publikation
- CARDIOVASC
Related Topics
You May Also Like
- Evidence, effectiveness and practical implications
Medicinal plants for allergic rhinitis
- Current status and future prospects
Cell and gene therapies in modern cardiology
- Cardiovascular risk and obesity
Pathomechanisms, secondary prevention and treatment options
- Patient-oriented recommendations for action
Effect of heat on diabetes technology
- Ventricular arrhythmias
Indication for ICD or WCD?
- Early breast cancer
Overweight and obesity worsen the prognosis
- Psoriasis treatment with biologics
What are the latest trends?
- Flu vaccination for older people